Evolving guidelines for molecular testing in lung cancer
The importance of knowing the molecular profile of a patient's tumor
Searching for new agents against lung cancer: the PROFILE 1014 and ALEX trials
Challenges and opportunities for patients with advanced NSCLC
Durvalumab: the new standard of care for NSCLC?